Transcriptional regulation of β2-microglobulin demonstrated via a novel genomic and proteomic analysis of percutaneously collected peripheral atheroma

Clinical and Translational Science

Volumn 1, Issue 3, 2008, Pages 240-244

  Stauffer, Brian L ^a,b,c   Kushner, Erich J ^c   Wulfman, Ted ^d   Zeller, Thomas ^e   Sobus, Rebecca ^a   Westby, Christian M ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Pathway Medical Technologies Inc   (United States)

^e UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; MESSENGER RNA;

ARTICLE; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TRANSCRIPTION REGULATION; WESTERN BLOTTING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ATHEROSCLEROSIS; BETA 2-MICROGLOBULIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENOMICS; HUMANS; PROTEOMICS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 77953468249     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2008.00071.x     Document Type: Article

References (28)

1. Miller DT, Ridker PM, Libby P, Kwiatkowski DJ. Atherosclerosis: The path from genomics to therapeutics. J Am Coll Cardiol. 2007; 49 (15): 1589-1599.
2. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature. 2008; 451 (7181): 904-913.
3. Zeller T, Krankenberg H, Rastan A, Sixt S, Schmidt A, Tubler T, Schwarz T, Frank U, Burgelin K, Schwarzwalder U, Hauswald K, Kliem M, Pochert V, Neumann FJ, Scheinert D. Percutaneous rotational and aspiration atherectomy in infrainguinal peripheral arterial occlusive disease: A multicenter pilot study. J Endovasc Ther. 2007; 14 (3): 357-364.
4. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999; 270 (1): 41-49.
5. Shevchenko A, Chernushevich I, Ens W, Standing KG, Thomson B, Wilm M, Mann M. Rapid "de novo"peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer. Rapid Commun Mass Spectrom. 1997; 11 (9): 1015-1024.
6. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2006; 1 (6): 2856-2860.
7. Bagnato C, Thumar J, Mayya V, Hwang SI, Zebroski H, Claffey KP, Haudenschild C, Eng JK, Lundgren DH, Han DK. Proteomics analysis of human coronary atherosclerotic plaque: A feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics. 2007; 6 (6): 1088-1102.
8. Donners MM, Verluyten MJ, Bouwman FG, Mariman EC, Devreese B, Vanrobaeys F, van Beeumen J, Van Den Akker LH, Daemen MJ, Heeneman S. Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J Pathol. 2005; 206 (1): 39-45.
9. Duran MC, Mas S, Martin-Ventura JL, Meilhac O, Michel JB, Gallego-Delgado J, Lazaro A, Tunon J, Egido J, Vivanco F. Proteomic analysis of human vessels: Application to atherosclerotic plaques. Proteomics. 2003; 3 (6): 973-978.
10. Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature. 2008; 451 (7181): 949-952.
11. Wilson AM, Kimura E, Harada RK, Nair N, Narasimhan B, Meng XY, Zhang F, Beck KR, Olin JW, Fung ET, Cooke JP. Beta2-microglobulin as a biomarker in peripheral arterial disease: Proteomic profiling and clinical studies. Circulation. 2007; 116 (12): 1396-1403.
12. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature. 2008; 451 (7181): 953-957.
13. Grines CL. The role of statins in reversing atherosclerosis: What the latest regression studies show. J Inteiv Cardiol. 2006; 19 (1): 3-9.
14. Lima JA, Desai MY, Steen H, Warren WP, Gautam S, Lai S. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation. 2004; 110 (16): 2336-2341.
15. Watts GF, Lewis B, Brunt JN, Lewis ES, Coltart DJ, Smith LD, Mann JI, Swan AV. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet. 1992; 339 (8793): 563-569.
16. Beschorner U, Goebel H, Rastan A, Sixt S, Zeller T. Histological diagnosis of atypical Takayasu arteritis using percutaneous transluminal atherectomy. J Endovasc Ther. 2008; 15 (2): 241-243.
17. Zeller T, Koch H, Frank U, Burgelin K, Schwarzwalder U, Muller C, Rastan A, Amantea P, Neumann FJ. Histological verification of non-specific aorta-arteritis (Takayasu's arteritis) using percutaneous transluminal atherectomy. Vasa. 2004; 33 (4): 247-251.
18. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med. 2002; 346 (18): 1357-1365.
19. Galkina E, Ley K. Leukocyte influx in atherosclerosis. Curr Drug Targets. 2007; 8 (12): 1239-1248.
20. Porn-Ares MI, Saido TC, Andersson T, Ares MP. Oxidized low-density lipoprotein induces calpain-dependent cell death and ubiquitination of caspase 3 in HMEC-1 endothelial cells. Biochem J. 2003; 374 (Pt 2): 403-411.
21. van Keulen JK, de Kleijn DP, Nijhuis MM, Busser E, Velema E, Fijnheer R, Van Der Graaf Y, Moll FL, de Vries JP, Pasterkamp G. Levels of extra domain A containing fibronectin in human atherosclerotic plaques are associated with a stable plaque phenotype. Atherosclerosis. 2007; 195 (1): E83-e91.
22. Kim MP, Zhou M, Wahl LM. Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture. J LeukocBiol. 2005; 78 (1): 195-201.
23. Palombo D, Maione M, Cifiello BI, Udini M, Maggio D, Lupo M. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta. J Cardiovasc Surg (Torino). 1999; 40 (2): 257-260.
24. Bark J, Murphy PM. Chemokine regulation of atherosclerosis. J Leukoc Biol. 2007; 82 (2): 226-236.
25. Galkina E, Kadi A, Sanders J, Varughese D, Sarembock IJ, Ley K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med. 2006; 203 (5): 1273-1282.
26. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007; 117 (1): 185-194.
27. Annex BH. Is a simple biomarker for peripheral arterial disease on the horizon? Circulation. 2007; 116 (12): 1346-1348.
28. Sanchez JC, Appel RD, Golaz O, Pasquali C, Ravier F, Bairoch A, Hochstrasser DF. Inside SWISS-2DPAGE database. Electrophoresis. 1995; 16 (7): 1131-1151.